Back to Search Start Over

Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection

Authors :
Anita GÄ…siorowska
Cezary Chojnacki
Aleksandra Kaczka
Jan Chojnacki
Cezary Rudnicki
Paulina Konrad
Source :
Gastroenterology Review, Vol 13, Iss 3, Pp 213-217 (2018)
Publication Year :
2018
Publisher :
Termedia Sp. z.o.o., 2018.

Abstract

Introduction Small intestinal bacterial overgrowth (SIBO) may coexist with Helicobacter pylori infection, which can be the cause of chronic gastrointestinal complaints. Aim Evaluation of the therapeutic efficacy of amoxicillin and rifaximin in the treatment of these diseases. Material and methods The lactulose hydrogen breath test (LHBT) and the urea breath test (13C-UBT) were performed in 116 patients. In 62 patients the coexistence of small intestinal bacterial overgrowth and H. pylori infection was observed. Then, in group I (n = 30) pantoprazole (2 × 40 mg), amoxicillin (2 × 1000 mg) and metronidazole (2 × 500 mg) and in group II (n = 32) pantoprazole and amoxicillin at the above doses and rifaximin (3 × 400 mg) were administered for 10 days. After 6 weeks, both breath tests were repeated and the degree of remission of symptoms was measured using a 10-point visual analog scale (VAS). Results After the treatment the LHBT index decreased in group I from 61.2 ±19.4 ppm to 22.0 ±8.2 ppm (p 0.05). The decrease of pain below 3.0 points in the VAS was obtained in 64.8% of patients in group I and in 56.2% in group II. Conclusions Combination of amoxicillin and rifaximin may be effective in the treatment of patients with small intestinal bacterial overgrowth syndrome and concomitant H. pylori infection.

Details

ISSN :
18955770
Volume :
13
Database :
OpenAIRE
Journal :
Gastroenterology Review
Accession number :
edsair.doi.dedup.....b76a9a4a19d9132ae313dd08c988b20b
Full Text :
https://doi.org/10.5114/pg.2018.74228